• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inadequate response to ustekinumab in atopic dermatitis - a report of two patients.

作者信息

Samorano L P, Hanifin J M, Simpson E L, Leshem Y A

机构信息

Department of Dermatology, Hospital das Clínicas, University of São Paulo Medical School, Sao Paulo, Brazil.

Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.

出版信息

J Eur Acad Dermatol Venereol. 2016 Mar;30(3):522-3. doi: 10.1111/jdv.12918. Epub 2014 Dec 16.

DOI:10.1111/jdv.12918
PMID:25510643
Abstract
摘要

相似文献

1
Inadequate response to ustekinumab in atopic dermatitis - a report of two patients.乌司奴单抗治疗特应性皮炎疗效不佳——两例患者报告
J Eur Acad Dermatol Venereol. 2016 Mar;30(3):522-3. doi: 10.1111/jdv.12918. Epub 2014 Dec 16.
2
Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.两例血清免疫球蛋白 E 水平升高的银屑病患者使用乌司奴单抗后特应性皮炎症状加重。
J Dermatol. 2018 Jun;45(6):732-734. doi: 10.1111/1346-8138.14295. Epub 2018 Mar 22.
3
Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.一名有儿童特应性病史的银屑病患者使用乌司奴单抗后特应性皮炎加重。
Allergol Int. 2015 Oct;64(4):382-3. doi: 10.1016/j.alit.2015.06.003. Epub 2015 Jul 8.
4
Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.在一名有恶性黑色素瘤病史的患者中使用优特克单抗进行银屑病的长期治疗。
Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12522. Epub 2017 Jul 21.
5
Atopic-like dermatitis after secukinumab injection: A case report.司库奇尤单抗注射后出现类特应性皮炎：一例报告。
Dermatol Ther. 2019 Jan;32(1):e12751. doi: 10.1111/dth.12751. Epub 2018 Nov 11.
6
A systematic review of ustekinumab in the treatment of atopic dermatitis.乌司奴单抗治疗特应性皮炎的系统评价。
J Dermatolog Treat. 2018 Sep;29(6):539-541. doi: 10.1080/09546634.2017.1406894. Epub 2018 Feb 5.
7
Remittive effect of Dupilumab in atopic dermatitis.度普利尤单抗在特应性皮炎中的缓解作用。
Dermatol Ther. 2018 Nov;31(6):e12711. doi: 10.1111/dth.12711. Epub 2018 Sep 25.
8
Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use.
J Am Acad Dermatol. 2020 Dec;83(6):1773-1775. doi: 10.1016/j.jaad.2020.03.074. Epub 2020 Apr 1.
9
CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis.CD4+ T 细胞耗竭使特应性皮炎小鼠模型中的细胞因子环境从 TH1/TH2 反应转变为 TC17 样反应。
Int Immunopharmacol. 2011 Sep;11(9):1285-92. doi: 10.1016/j.intimp.2011.04.010. Epub 2011 Apr 28.
10
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.严重特应性皮炎的特征是循环中 TH2/TC2 和 TH22/TC22 细胞而非 TH17/TC17 细胞的选择性扩增，这些细胞存在于皮肤归巢 T 细胞群中。
J Allergy Clin Immunol. 2015 Jul;136(1):104-115.e7. doi: 10.1016/j.jaci.2015.01.020. Epub 2015 Mar 3.

引用本文的文献

1
Associations of 2923 plasma proteins with incident atopic dermatitis in a prospective cohort study and genetic analysis.一项前瞻性队列研究和基因分析中2923种血浆蛋白与特应性皮炎发病的关联
Medicine (Baltimore). 2025 Jul 18;104(29):e43447. doi: 10.1097/MD.0000000000043447.
2
Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization.通过人类血浆蛋白质组学和孟德尔随机化综合分析揭示银屑病的新型蛋白质生物标志物
Psoriasis (Auckl). 2024 Dec 7;14:179-193. doi: 10.2147/PTT.S492205. eCollection 2024.
3
Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics.
通过整合人类血浆蛋白质组学和基因组学分析揭示痤疮的新蛋白质生物标志物和治疗靶点。
Front Immunol. 2024 Oct 18;15:1452801. doi: 10.3389/fimmu.2024.1452801. eCollection 2024.
4
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.乌司奴单抗在非适应证皮肤科疾病中的其他用途：系统评价。
Arch Dermatol Res. 2022 Aug;314(6):503-514. doi: 10.1007/s00403-021-02262-7. Epub 2021 Jun 22.
5
The Role of Th17-Related Cytokines in Atopic Dermatitis.Th17 相关细胞因子在特应性皮炎中的作用。
Int J Mol Sci. 2020 Feb 15;21(4):1314. doi: 10.3390/ijms21041314.
6
Biological therapies for atopic dermatitis: An update.特应性皮炎的生物疗法：最新进展
Exp Ther Med. 2019 Feb;17(2):1061-1067. doi: 10.3892/etm.2018.6989. Epub 2018 Nov 19.
7
Clinical approach to the patient with refractory atopic dermatitis.难治性特应性皮炎患者的临床诊治方法
Ann Allergy Asthma Immunol. 2018 Jan;120(1):23-33.e1. doi: 10.1016/j.anai.2017.09.061.
8
Immune response patterns in non-communicable inflammatory skin diseases.非传染性炎症性皮肤病的免疫反应模式。
J Eur Acad Dermatol Venereol. 2018 May;32(5):692-703. doi: 10.1111/jdv.14673. Epub 2018 Jan 15.
9
Systemic Treatment of Adult Atopic Dermatitis: A Review.成人特应性皮炎的全身治疗：综述
Dermatol Ther (Heidelb). 2017 Mar;7(1):1-23. doi: 10.1007/s13555-016-0170-1. Epub 2016 Dec 26.
10
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.优特克单抗治疗中重度特应性皮炎成人患者的疗效和安全性。
Exp Dermatol. 2017 Jan;26(1):28-35. doi: 10.1111/exd.13112. Epub 2016 Aug 9.